4//SEC Filing
Kim Lorence H. 4
Accession 0001610717-23-000130
CIK 0001628171other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:13 PM ET
Size
6.6 KB
Accession
0001610717-23-000130
Insider Transaction Report
Form 4
Kim Lorence H.
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-08+18,400→ 18,400 totalExercise: $24.84Exp: 2033-06-07→ Common Stock (18,400 underlying) - Award
Common Stock
2023-06-08+5,200→ 65,700 total
Footnotes (2)
- [F1]Includes 13,950 Restricted Stock Units.
- [F2]Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 8, 2023 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001643746
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:13 PM ET
- Size
- 6.6 KB